These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 20713847

  • 1. Astrocytoma in a breast cancer lineage: part of the BRCA2 phenotype?
    Wilson BT, Douglas SF, Polvikoski T.
    J Clin Oncol; 2010 Oct 20; 28(30):e596-8. PubMed ID: 20713847
    [No Abstract] [Full Text] [Related]

  • 2. Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family.
    Diez O, Gutiérrez-Enríquez S, Masas M, Tenés A, Yagüe C, Arcusa A, Llort G.
    Breast Cancer Res Treat; 2010 Sep 20; 123(2):587-90. PubMed ID: 20232139
    [Abstract] [Full Text] [Related]

  • 3. Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side.
    Garber JE, Golshan M.
    J Clin Oncol; 2009 Dec 10; 27(35):5862-4. PubMed ID: 19858367
    [No Abstract] [Full Text] [Related]

  • 4. Two founder BRCA2 mutations predispose to breast cancer in young women.
    Infante M, Durán M, Lasa A, Acedo A, de la Hoya M, Esteban-Cardeñosa E, Sanz DJ, Pérez-Cabornero L, Lastra E, Miner C, Velasco EA.
    Breast Cancer Res Treat; 2010 Jul 10; 122(2):567-71. PubMed ID: 19949853
    [Abstract] [Full Text] [Related]

  • 5. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N, Preisler-Adams S, Nestle-Kraemling C, Zaino M, Loeffler M, Kiechle M, Meindl A, Varga D, Schmutzler RK.
    J Clin Oncol; 2009 Dec 10; 27(35):5887-92. PubMed ID: 19858402
    [Abstract] [Full Text] [Related]

  • 6. Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.
    Arnold JM, Choong DY, Thompson ER, kConFab, Waddell N, Lindeman GJ, Visvader JE, Campbell IG, Chenevix-Trench G.
    Breast Cancer Res Treat; 2010 Jan 10; 119(2):491-6. PubMed ID: 19189213
    [Abstract] [Full Text] [Related]

  • 7. Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.
    Machado PM, Brandão RD, Cavaco BM, Eugénio J, Bento S, Nave M, Rodrigues P, Fernandes A, Vaz F.
    J Clin Oncol; 2007 May 20; 25(15):2027-34. PubMed ID: 17513806
    [Abstract] [Full Text] [Related]

  • 8. Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.
    Domchek SM, Gaudet MM, Stopfer JE, Fleischaut MH, Powers J, Kauff N, Offit K, Nathanson KL, Robson M.
    Breast Cancer Res Treat; 2010 Jan 20; 119(2):409-14. PubMed ID: 19885732
    [Abstract] [Full Text] [Related]

  • 9. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.
    Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G.
    Cancer Epidemiol Biomarkers Prev; 2002 Apr 20; 11(4):413-6. PubMed ID: 11927503
    [Abstract] [Full Text] [Related]

  • 10. Association of invasive breast carcinoma and multicentric high grade astrocytoma: a case report with a review.
    Pour PH, Forouzandeh M, Beni AN, Beni ZN, Hoseinpour P.
    Eur Rev Med Pharmacol Sci; 2011 Mar 20; 15(3):337-44. PubMed ID: 21528782
    [Abstract] [Full Text] [Related]

  • 11. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL, Smith AM, Dávila MR, Sigurdson AJ, Giusti RM, Pineda MA, Doody MM, Tucker MA, Greene MH, Zhang J, Struewing JP.
    Hum Mutat; 2003 Aug 20; 22(2):121-8. PubMed ID: 12872252
    [Abstract] [Full Text] [Related]

  • 12. Solitary brain metastasis in a patient with ovarian cancer with BRCA2 mutation.
    Root K, Armaghany T.
    J Clin Oncol; 2012 Sep 01; 30(25):e239-40. PubMed ID: 22753899
    [No Abstract] [Full Text] [Related]

  • 13. Molecular and pathological characterization of inherited breast cancer.
    Borg A.
    Semin Cancer Biol; 2001 Oct 01; 11(5):375-85. PubMed ID: 11562180
    [Abstract] [Full Text] [Related]

  • 14. Origin and distribution of the BRCA2-8765delAG mutation in breast cancer.
    Palomba G, Cossu A, Friedman E, Budroni M, Farris A, Contu A, Pisano M, Baldinu P, Sini MC, Tanda F, Palmieri G.
    BMC Cancer; 2007 Jul 19; 7():132. PubMed ID: 17640379
    [Abstract] [Full Text] [Related]

  • 15. Screening for RAD51 and BRCA2 BRC repeat mutations in breast and ovarian cancer families.
    Rapakko K, Heikkinen K, Karppinen SM, Winqvist R.
    Cancer Lett; 2006 May 08; 236(1):142-7. PubMed ID: 16005565
    [Abstract] [Full Text] [Related]

  • 16. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
    Meyer P, Voigtlaender T, Bartram CR, Klaes R.
    Hum Mutat; 2003 Sep 08; 22(3):259. PubMed ID: 12938098
    [Abstract] [Full Text] [Related]

  • 17. BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families.
    Azzouzi AR, Stoppa-Lyonnet D, Roupret M, Larre S, Mangin P, Cussenot O.
    Int J Urol; 2007 May 08; 14(5):445-6. PubMed ID: 17511731
    [Abstract] [Full Text] [Related]

  • 18. Hereditary breast/ovarian cancer: clinicopathological characteristics and survival of BRCA2 positive and negative cases.
    Syamala V, Syamala VS, Sreeja L, Raveendran PB, Vijayalekshmi RV, Sheeja VR, Santhi S, Kuttan R, Abraham EK, Ankathil R.
    J Exp Ther Oncol; 2008 May 08; 7(3):227-36. PubMed ID: 19066131
    [Abstract] [Full Text] [Related]

  • 19. BCoR-L1 variation and breast cancer.
    Lose F, Arnold J, Young DB, Brown CJ, Mann GJ, Pupo GM, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Khanna KK, Chenevix-Trench G, Spurdle AB.
    Breast Cancer Res; 2007 May 08; 9(4):R54. PubMed ID: 17697391
    [Abstract] [Full Text] [Related]

  • 20. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
    Nowacka-Zawisza M, Brys M, Romanowicz-Makowska H, Kulig A, Krajewska WM.
    Pathol Int; 2008 May 08; 58(5):275-81. PubMed ID: 18429825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.